![]() OS Therapies OS Therapies (OST) is a therapeutic company focused on identifying, developing, and commercializing treatments for osteosarcoma. | Andarix Pharmaceuticals Andarix Pharmaceuticals is a company developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond. | ![]() Vivesto Vivesto (formerly known as Oasmia Pharmaceutical) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology. | |||
Founding Date | Founding Date 1939 | Founding Date 2018 | Founding Date 2018 | Founding Date N/A | Founding Date 1990 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Buenos Aires, AR HQ | Locations Geneva, CH HQ | Locations Rockville, US HQ | Locations HQ | Locations Uppsala, SE HQ Solna, SE |
Employees | Employees 1,5791% increase | Employees 7 | Employees 4 | Employees N/A | Employees 4 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 55.5 m | Valuation ($) N/A | Valuation ($) 13.6 m |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($28.8m) (FY, 2025) | Net income N/A | Net income (kr34.1m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.6m | Total funding raised $ 6m | Total funding raised N/A | Total funding raised $ 19.3m |
MPC Therapeutics is a company that develops drugs for mitochondria.
View company
OS Therapies (OST) is a therapeutic company focused on identifying, developing, and commercializing treatments for osteosarcoma.
View companyAndarix Pharmaceuticals is a company developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond.
View company
Vivesto (formerly known as Oasmia Pharmaceutical) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology.
View company